arbekacin has been researched along with Cross Infection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akashi, K; Chong, Y; Harada, Y; Kadowaki, M; Miyake, N; Shimoda, S; Shimono, N; Uchida, Y | 1 |
| Akamatsu, N; Hasegawa, H; Kawakami, K; Kimura, Y; Kosai, K; Matsuda, J; Matsuo, H; Morinaga, Y; Uno, N; Yamaryo, T; Yanagihara, K | 1 |
| Niki, Y | 1 |
| Suzuki, K | 1 |
| Endo, K; Fukuda, M; Hashikita, G; Itabashi, A; Maesaki, S; Tominaga, K; Yamazaki, T | 1 |
| Sunakawa, K | 1 |
| Akama, H; Barada, K; Hanaki, H; Ikeda, S; Inamatsu, T; Nakae, T; Sunakawa, K; Yamaguchi, Y | 1 |
| Hasobe, T; Ida, T; Inoue, M; Nonoyama, M; Okamoto, R; Okubo, T; Shimauchi, C | 1 |
| Natori, H; Oizumi, K; Tanaka, K; Tokunaga, N | 1 |
| Fujita, J; Hojo, S; Ichiyama, S; Kawanishi, K; Miyawaki, H; Negayama, K; Obayashi, Y; Takahara, J; Takashima, C; Tanabe, T; Yamaji, Y | 1 |
| Fukayama, M | 1 |
| Watanabe, A | 1 |
3 review(s) available for arbekacin and Cross Infection
| Article | Year |
|---|---|
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
[Treatment of cancer and counter-measures for MRSA infections].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Cross Infection; Dibekacin; Disinfection; Female; Humans; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Patient Isolation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[Methicillin resistant Staphylococcus aureus infection].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
9 other study(ies) available for arbekacin and Cross Infection
| Article | Year |
|---|---|
Nosocomial spread of meticillin-resistant Staphylococcus aureus with β-lactam-inducible arbekacin resistance.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dibekacin; DNA Transposable Elements; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA; Staphylococcal Infections; Transcriptional Activation | 2014 |
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cross Infection; Daptomycin; Dibekacin; Exotoxins; Humans; Japan; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Open Reading Frames; Recombinases; Secondary Care Centers; Skin; Soft Tissue Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Efficacy and safety of arbekacin for staphylococcal infection in the NICU.
Topics: Aminoglycosides; Anti-Bacterial Agents; Creatinine; Cross Infection; Dibekacin; Evoked Potentials, Auditory, Brain Stem; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Methicillin Resistance; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2003 |
[Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
Topics: Aminoglycosides; Cross Infection; Dibekacin; Drug Resistance, Bacterial; Epidemiologic Studies; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 2004 |
[Appropriate use of anti-MRSA drugs (discussion)].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Dibekacin; Humans; Immunocompromised Host; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Hospitals, Convalescent; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Tokyo | 2007 |
[Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus | 1994 |
Investigation of nosocomial infection caused by arbekacin-resistant, methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Methicillin Resistance; Middle Aged; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus | 1997 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |